Table 4 Use of selected non-pain-related medications among study subjects*
Patients with painful neuropathies (N = 31,688) | Comparison group (N = 31,688) | P-Value | |
|---|---|---|---|
Number receiving | |||
General anti-infectives systemic | 14,451 (45.6) | 10,953 (34.6) | <0.01 |
Cough and cold preparations | 6,682 (21.1) | 5,188 (16.4) | <0.01 |
Dermatologicals | 7,464 (23.6) | 5,415 (17.1) | <0.01 |
ACE inhibitors | 8,421 (26.6) | 5,327 (16.8) | <0.01 |
Antiulcerants | 7,525 (23.7) | 3,819 (12.1) | <0.01 |
Beta-blocking agents | 6,148 (19.4) | 4,446 (14.0) | <0.01 |
Anti-asthma and COPD products | 5,534 (17.5) | 3,450 (10.9) | <0.01 |
Drugs used in diabetes | 4,553 (14.4) | 3,996 (12.6) | <0.01 |
Diuretics | 5,081 (16.0) | 4,224 (13.3) | <0.01 |
Plain antispasmodics and anticholinergics | 6,267 (19.8) | 4,133 (13.0) | <0.01 |
Thyroid therapy | 3,909 (12.3) | 3,494 (11.0) | <0.01 |
Calcium antagonists | 4,340 (13.7) | 3,565 (11.3) | <0.01 |
Statins | 4,377 (13.8) | 1,900 (6.0) | <0.01 |
Antidiarrhoeals, oral electrolyte replacers and intestinal anti-inflammatories | 3,336 (10.5) | 2,116 (6.7) | <0.01 |
Non-narcotics and anti-pyretics | 2,711 (8.6) | 1,802 (5.7) | <0.01 |
Respiratory system and nasal preparations | 2,558 (8.1) | 1,722 (5.4) | <0.01 |
Angiotensin-II antagonists | 2,532 (8.0) | 1,764 (5.6) | <0.01 |
Heparins | 2,412 (7.6) | 1,573 (5.0) | <0.01 |
Ophthalmologicals | 2,158 (6.8) | 1,581 (5.0) | <0.01 |
Urologicals | 2,614 (8.2) | 1,406 (4.4) | <0.01 |
Systemic antihistamines | 2,313 (7.3) | 1,797 (5.7) | <0.01 |
Anti-gout preparations | 2,305 (7.3) | 1,531 (4.8) | <0.01 |
Nitrites and nitrates | 2,016 (6.4) | 991 (3.1) | <0.01 |
Mineral supplements | 2,173 (6.9) | 1,393 (4.4) | <0.01 |
Diagnostic agents | 2,201 (6.9) | 1,090 (3.4) | <0.01 |
Number receiving | <0.01 | ||
None of the above | 5,114 (16.1) | 8,329 (26.3) | |
1 of the above | 5,020 (15.8) | 6,513 (20.6) | |
2 of the above | 4,329 (13.7) | 4,460 (14.1) | |
3 of the above | 3,612 (11.4) | 3,415 (10.8) | |
≥ 4 of above | 13,613 (43.0) | 8,971 (28.3) | |
Any of above | 26,574 (83.9) | 23,359 (73.7) | <0.01 |